EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis

Tanshinon IIA mildert kognitive Beeinträchtigung bei Ratten mit vaskulärer Demenz durch Modulation der Kupferhomöostase über die SLC31A1/FDX1-Achse

Hongxiao Lv, Xinyu Yang, Yutong Liu, Junwei Zhou, Wentao Yu iD

PLOS One · 24.08.2026 · 21 (8) · e0356885

DOI: 10.1371/journal.pone.0356885 ↗

Auf einen Blick

In einem Rattenmodell der vaskulären Demenz verringerte Tanshinon IIA kognitive Störungen und neuronale Schäden. Die Effekte gingen mit veränderten Cuproptose-bezogenen Proteinen und weniger Kupferakkumulation einher.

Fragestellung

Wirkt Tanshinon IIA im Rattenmodell der vaskulären Demenz auf Kognition, neuronale Schädigung und cuproptosebezogene Mechanismen?

Methode

Rattenmodell der vaskulären Demenz durch bilaterale Karotisligatur (2-VO) mit Tanshinon-IIA-Behandlung; Morris-Water-Maze, HE- und Nissl-Färbung, TEM und Western Blot. In vitro HT-22-Zellen nach OGD/R mit CCK-8, ROS- und Kupfermessung.

Ergebnisse

Tanshinon IIA verbesserte die kognitive Funktion und verringerte neuronale Schädigung im Hippocampus. Es veränderte cuproptosebezogene Proteine, senkte oxidativen Stress und Kupferakkumulation und schützte Mitochondrien.

Schlussfolgerung der Autor:innen

Tanshinon IIA verringerte kognitive Beeinträchtigung und neuronale Verletzung bei vaskulärer Demenz und wirkte neuroprotektiv durch Abschwächung kupferabhängiger Zytotoxizität, Erhalt der Mitochondrien und Modulation der SLC31A1/FDX1-Achse.

Kernaussagen

  • Rattenmodell der vaskulären Demenz
  • Bessere Kognition und weniger neuronale Schädigung
  • Zusammenhang mit Kupferhomöostase und Mitochondrien

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 24.08.2026. Verfasst von Hongxiao Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hebei University of Chinese Medicine, Shijiazhuang, China. Hauptthemen laut MEDLINE: Abietanes, Dementia, Vascular, Copper, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Natural Science Foundation Project, Hebei Provincial Administration of Traditional Chinese Medicine Research Project.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tanshinone IIA (TSA) is the core liposoluble active component of Salvia miltiorrhiza , a traditional Chinese medicine, and exhibits multiple pharmacological activities including anti-inflammation, anti-oxidation, anti-apoptosis and mitochondrial function improvement. Studies have confirmed that TSA can ameliorate cognitive function in rats with vascular dementia (VaD) by alleviating cerebral ischemic injury, inhibiting neuroinflammation, protecting the blood-brain barrier and other pathways. However, it has not been reported whether TSA exerts its neuroprotective effect by regulating the cuproptosis pathway. Focusing on cuproptosis, this study investigated the effects of TSA on cognitive impairment, neuronal injury and cuproptosis-related mechanisms in a rat model of VaD.

Methods

A rat model of VaD was established by permanent bilateral common carotid artery ligation (2-VO), and the model rats were treated with TSA. The cognitive impairment of VaD rats was evaluated by the Morris water maze test. Hematoxylin-eosin (HE) staining and Nissl staining were used to detect neuronal injury and loss in the hippocampus of VaD rats. Transmission electron microscopy (TEM) was performed to observe the ultrastructure of mitochondria in the hippocampus; Western blot (WB) assay was adopted to detect the expression levels of cuproptosis-related proteins, including solute carrier family 31 member 1 (SLC31A1), ferredoxin 1 (FDX1), lipoic acid synthetase (LIAS) and dihydrolipoamide transacetylase (DLAT).In vitro, an oxygen-glucose deprivation/reoxygenation (OGD/R) model was established in HT-22 cells to evaluate the effects of TSA on cell viability (CCK-8), intracellular reactive oxygen species (ROS) levels, and copper accumulation (Coppersensor-1 staining), further validating the involvement of copper homeostasis in TSA-mediated neuroprotection.

Results

The results revealed that TSA markedly alleviated cognitive dysfunction and neuronal damage in VaD rats. It also reversed the cuproptosis-related abnormal changes in the brain of VaD rats, and modulated the expression of SLC31A1/FDX1 pathway proteins. In vitro, TSA protected HT-22 cells from OGD/R-induced injury by reducing oxidative stress and copper accumulation.These changes were associated with amelioration of copper overload and mitochondrial damage, suggesting that TSA may exert neuroprotection partially through the regulation of cuproptosis-related pathways.

Conclusion

TSA effectively alleviated cognitive impairment and neuronal injury in VaD rats, and exerted neuroprotective effects both in vivo and in vitro by attenuating copper-dependent cytotoxic stress, preserving mitochondrial integrity, and modulating the SLC31A1/FDX1 axis. This study provides a new perspective and theoretical basis for the future development of targeted drugs for VaD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AbietanesDementia, VascularCopperCognitive DysfunctionCopper Transporter 1Neuroprotective AgentsAnimalsRatsMaleHomeostasisRats, Sprague-DawleyCuproptosisMitochondriaHippocampusDisease Models, Animal

Substanzen

AbietanestanshinoneCopperCopper Transporter 1Neuroprotective Agents

Autor:innen und Institutionen

  • Hebei University of Chinese Medicine, Shijiazhuang, China.
  • Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Hebei International Joint Research Center for Dominant Diseases in Chinese Medicine and Acupuncture, Shijiazhuang, China.
  • Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Diseases, Shijiazhuang, China.

ORCID-Profile: Wentao Yu

Förderung

  • Hebei Province Natural Science Foundation Project
  • Hebei Provincial Administration of Traditional Chinese Medicine Research Project

Zitieren

APA

Lv, H., Yang, X., Liu, Y., Zhou, J., & Yu, W. (2026). Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis. PLOS One, 21(8), e0356885. https://doi.org/10.1371/journal.pone.0356885

Vancouver

Lv H, Yang X, Liu Y, Zhou J, Yu W. Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis. PLOS One. 2026;21(8):e0356885. doi:10.1371/journal.pone.0356885

BibTeX
@article{Lv2026,
  author = {Lv, Hongxiao and Yang, Xinyu and Liu, Yutong and Zhou, Junwei and Yu, Wentao},
  title = {Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0356885},
  doi = {10.1371/journal.pone.0356885}
}
Kostenlos starten →